Interprofessional Pharmacogenomics (IPGx) Registry and Repository

Part of paid clinical trials in Bryan, Texas.

Sponsor
Texas A&M University
Study ID
NCT06726590
Status
Recruiting
Apply to this trial

Conditions

  • Adverse Drug Reaction (ADR)
  • Blood Pressure Disorders
  • COPD
  • Cancer
  • Cholesterol
  • Diabetes
  • Heart Disease
  • Poly Pharmacy
  • Respiratory Ilness

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This program collects genetic and health information to help doctors choose the right medications for patients.

Key Dates

Start date
Nov 30, 2025
Status verified
Nov 2024
Primary completion
Nov 30, 2029
Completion
Nov 30, 2029

Study Design

Enrollment
3,000 participants (estimated)

Arms

  • Arm: Polypharmacy
    Patients taking many medications or medications with severe side effects

Primary Outcome Measure

Frequency and nature of ADRs on the Naranjo Scale [ Time Frame: 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Texas A&M Family CareBryanTexas77802
Sara Rogers, PharmD
[email protected]
979.776.8440
[email protected]
Kenneth S Kenneth S. Ramos, MD, PhD (PRINCIPAL_INVESTIGATOR)
Gabriel Neal, MD (SUB_INVESTIGATOR)
Sara Rogers, PharmD (SUB_INVESTIGATOR)
Rick Silva, PhD (SUB_INVESTIGATOR)
George Udeani, PharmD, DSC, FCP, FCCP (SUB_INVESTIGATOR)
Asim Abu-Baker, PharmD (SUB_INVESTIGATOR)
Fen Wang, PhD (SUB_INVESTIGATOR)
Marcia Ory, PhD (SUB_INVESTIGATOR)

Find similar trials in Bryan, TX

By condition
COPD
By specialty
PulmonologyLung disease
By research site
Texas A&M Family Care· Bryan, TX

Related Studies